Stoke Therapeutics, Inc.

STOK

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001623526

SEC filings (opens in a new tab)

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Stoke Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of STOK: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Q2 2024	Change
Holders	103	115	+12
Shares	54.2M	61.3M	+7.09M (+13.1%)
Value	$731.7M	$828.5M	+$96.8M (+13.2%)

New holders (34)

Institutions that held Stoke Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to STOK in Q2 2024
Institution	Shares	Value	% of portfolio
Assenagon Asset Management S.A.	1,468,202	$19.8M	0.05%
Logos Global Management LP	1,050,000	$14.2M	1.63%
Invesco Ltd.	437,136	$5.91M	0.00%
Voloridge Investment Management, LLC	198,280	$2.68M	0.01%
Silverarc Capital Management, LLC	141,518	$1.91M	0.47%
Walleye Capital LLC	126,830	$1.71M	0.02%
Qube Research & Technologies Ltd	97,798	$1.32M	0.00%
Rafferty Asset Management, LLC	79,885	$1.08M	0.00%
Swiss National Bank	66,400	$897.1K	0.00%
UBS Asset Management Americas Inc	57,399	$775.5K	0.00%
Verition Fund Management LLC	44,205	$597.2K	0.00%
Jump Financial, LLC	34,277	$463.1K	0.01%
Engineers Gate Manager LP	27,924	$377.3K	0.01%
EntryPoint Capital, LLC	25,926	$350.3K	0.16%
Two Sigma Advisers, LP	19,700	$266.1K	0.00%
Corebridge Financial, Inc.	19,133	$258.5K	0.00%
Janus Henderson Group PLC	18,900	$255.0K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	17,651	$237.9K	0.00%
Profund Advisors LLC	14,893	$201.2K	0.01%
Voya Investment Management LLC	11,932	$161.2K	0.00%
Ameriprise Financial Inc	10,305	$139.2K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	9,129	$123.3K	0.00%
Virtus ETF Advisers LLC	5,167	$69.8K	0.03%
STRS Ohio	2,300	$31.1K	0.00%
Quest Partners LLC	2,110	$28.5K	0.00%
Russell Investments Group, Ltd.	1,527	$20.6K	0.00%
Pacer Advisors, Inc.	454	$6.13K	0.00%
US Bancorp	396	$5.35K	0.00%
SRS Capital Advisors, Inc.	173	$2.34K	0.00%
Quarry LP	118	$1.59K	0.00%
CWM, LLC	110	$1.00K	0.00%
Planning Capital Management Corp	70	$946	0.00%
Harbour Investments, Inc.	50	$676	0.00%
Rothschild Investment LLC	30	$405	0.00%

Sold out (22)

Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of STOK in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Artal Group S.A.	300,000	$4.05M
Point72 Asset Management, L.P.	142,458	$1.92M
Laurion Capital Management LP	100,000	$1.35M
Maven Securities LTD	100,000	$1.35M
Gsa Capital Partners LLP	97,508	$1.32M
Monashee Investment Management LLC	67,584	$912.4K
Mirae Asset Global Investments Co., Ltd.	90,663	$728.0K
Norges Bank	50,000	$675.0K
LMR Partners LLP	50,000	$675.0K
Seven Grand Managers, LLC	30,000	$405.0K
Belvedere Trading LLC	23,665	$319.5K
Zacks Investment Management	21,439	$289.4K
Hudson Bay Capital Management LP	20,000	$270.0K
Bridgeway Capital Management, LLC	17,100	$230.8K
XTX Topco Ltd	16,308	$220.2K
American International Group, Inc.	13,738	$185.5K
Principal Financial Group Inc	10,451	$141.1K
Aquatic Capital Management LLC	9,600	$129.6K
State Board of Administration of Florida Retirement System	10,473	$87.2K
ADAR1 Capital Management, LLC	2,900	$39.1K
Metropolitan Life Insurance Co	1,625	$21.9K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	5	$67